EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+16.04%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$677M
AUM Growth
+$37.3M
(+5.8%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-7.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$39.9M |
| 2 |
Axogen
AXGN
|
+$10.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
MiMedx Group
MDXG
$1.03B
| $292M | 43.2% |
23,376,623
| – | – |
|
2
Bioventus
BVS
$464M
| $213M | 31.45% |
12,096,702
| – | – |
|
3
Venus Concept
VERO
$4.35M
| $38.6M | 5.7% |
75,260
| – | – |
|
4
EyePoint Pharmaceuticals
EYPT
$944M
| $37.7M | 5.57% |
4,190,921
| – | – |
|
|
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
| $37.3M | 5.51% |
1,333,692
-1,426,258
| -52% | -$39.9M |
|
|
6
Axogen
AXGN
$773M
| $27.6M | 4.08% |
1,276,645
-483,054
| -27% | -$10.4M |
|
7
TELA Bio
TELA
$60.6M
| $25.5M | 3.76% |
1,580,089
| – | – |
|
8
MediciNova
MNOV
$60.3M
| $4.7M | 0.69% |
1,105,941
| – | – |
|
9
Gyre Therapeutics
GYRE
$691M
| $340K | 0.05% |
10,483
| – | – |
|